Last edition
News about Global Pharma
The launch will be driven by its longstanding commercial partner, who have represented OrthAlign in the market since 2013 and supported over 68,000 OrthAlign cases.
Global Pharma | 16/05/2024 | By Manvi | 287
Avidity Biosciences Welcomes Simona Skerjanec to its Board of Directors
Avidity Biosciences, Inc. has strengthened its leadership with the appointment of Simona Skerjanec, M.Pharm, MBA to its board of directors.
Global Pharma | 16/05/2024 | By Aishwarya | 271
Cipla Extends its Investment in Achira to Advance in PoC Diagnostic
Cipla Ltd. has signed definitive agreements for further investment of up to INR 26 crore in Optionally Convertible Preference Shares of Achira Labs Pvt. Ltd., in four tranches, subject to completion of certain milestones.
Global Pharma | 16/05/2024 | By Aishwarya | 1113
Atraverse Medical Receives FDA Clearance for HOTWIRE Radiofrequency Guidewire
This device enables zero exchange left-heart access while also serving as a rail for catheter-based therapy systems.
Global Pharma | 16/05/2024 | By Abha | 651
Teva Names Matthew Shields as New Executive Vice President
Teva Pharmaceutical Industries Ltd. has appointed Matthew Shields as Executive Vice President of Teva Global Operations (TGO) under manufacturing and supply division
Global Pharma | 16/05/2024 | By Aishwarya | 1071
Lupin Secures ISO 14001 and ISO 45001 Certification for its Indian Sites and Centers
Lupin Ltd. has announced that all 12 of its manufacturing sites, its R&D Center, and its corporate office in India have completed rigorous audits and been certified by DNV for ISO 14001 — Environment Management Systems (EMS), and ISO 45001 — Occupational Health and Safety Management System (OHSMS).
Global Pharma | 16/05/2024 | By Aishwarya | 774
Activities are currently underway to finalize the seamless Phase 2/3 master protocol design that will evaluate multiple investigational therapies for the treatment of pancreatic cancer. An intent of the study is to produce registration-enabling data.
Global Pharma | 15/05/2024 | By Manvi | 516
Aurora Cannabis Appoints Rajesh Uttamchandani to Board of Directors
Rajesh Uttamchandani joins the Board with notable expertise in strategy development, innovation, human capital and governanc
Global Pharma | 15/05/2024 | By Manvi | 893
Aldevron Inks Strategic Partnership with Acuitas Therapeutics
Aldevron has forged a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNPs).
Global Pharma | 15/05/2024 | By Aishwarya | 804
FogPharma and ARTBIO to Co-Develop HEARTS for Treatment of Cancer
FogPharma has collaborated with ARTBIO to co-develop Helicon-enabled ARTs (HEARTs) to transform outcomes for patients with multiple types of cancer.
Global Pharma | 15/05/2024 | By Aishwarya | 304
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy